Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
UBS
Accenture
Colorcon
US Department of Justice
McKesson
US Army
Moodys
Express Scripts

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020864

« Back to Dashboard

NDA 020864 describes MAXALT, which is a drug marketed by Merck and is included in two NDAs. It is available from one supplier. Additional details are available on the MAXALT profile page.

The generic ingredient in MAXALT is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.
Summary for 020864
Tradename:MAXALT
Applicant:Merck
Ingredient:rizatriptan benzoate
Patents:0
Therapeutic Class:Antimigraine Agents
Pharmacology for NDA: 020864
Suppliers and Packaging for NDA: 020864
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MAXALT rizatriptan benzoate TABLET;ORAL 020864 NDA Merck Sharp & Dohme Corp. 0006-0266 N 0006-0266-18
MAXALT rizatriptan benzoate TABLET;ORAL 020864 NDA Merck Sharp & Dohme Corp. 0006-0267 N 0006-0267-18

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE
Approval Date:Jun 29, 1998TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Jun 29, 1998TE:ABRLD:Yes

Expired US Patents for NDA 020864

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck MAXALT rizatriptan benzoate TABLET;ORAL 020864-002 Jun 29, 1998 ➤ Sign Up ➤ Sign Up
Merck MAXALT rizatriptan benzoate TABLET;ORAL 020864-002 Jun 29, 1998 ➤ Sign Up ➤ Sign Up
Merck MAXALT rizatriptan benzoate TABLET;ORAL 020864-001 Jun 29, 1998 ➤ Sign Up ➤ Sign Up
Merck MAXALT rizatriptan benzoate TABLET;ORAL 020864-001 Jun 29, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Mallinckrodt
Citi
Baxter
Argus Health
Cerilliant
Boehringer Ingelheim
Accenture
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.